ClinicalTrials.gg
RecruitingNCT07637994J-ECHO OPSUpdated Oct 19, 2026

Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes

An interventional study of Project ECHO in Opioid Abuse (Disorder), sponsored by University of Massachusetts, Worcester. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by University of Massachusetts, Worcester · Not applicable, Interventional, and Health services research

How we know

Updated Oct 19, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,223 studies in Opioid-Related Disorders with a site in United States — 246 open to participants now, 316 under way, 18 of them phase 3. Opioid-Related Disorders · United States.

Planned enrollment
388th of 1,098
100 · median 56
Started
2027
with 17 others
No phase
571 of 1,223
133 open now
Primary completion
2030-02
later than 302 of 315 live
Registered
1,191st of 1,223
by date

Among the 1,223 studies in Opioid-Related Disorders with a site in United States, this one is the 388th largest by planned enrollment of the 1,098 interventional ones that give a count, is one of 18 that started in 2027, is one of 571 with no phase, reaches primary completion later than 302 of the 315 other live ones, and was the 1,191st registered.

Opioid-Related Disorders

1,476 studies on the registry are indexed under Opioid-Related Disorders; 293 are open to participants now.

Browse Opioid-Related Disorders studies →

Open to participants now

246 of the 1,223 studies in Opioid-Related Disorders with a site in United States are open now. Recruiting first, the newest first:

240 more — sign in →

All 246 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 213 Opioid-Related Disorders studies recruiting now, 123 (58%) set no upper age limit and 76 (36%) stop at 75 or younger; 14 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,223 studies in Opioid-Related Disorders with a site in United States, or all of them as a file.
02

Study summary

This project tests a training strategy to help rural jails start or increase their use of medications to treat opioid use disorder (MOUD - methadone, buprenorphine, naltrexone). Staff from participating jails will attend a series of training sessions, called Project ECHO, that include online learning sessions with skilled experts, case-based discussions (real-world examples), and peer-to-peer learning opportunities. Project ECHO is well-studied in healthcare settings but has rarely been used in correctional systems. Staff from 40 rural jails and local treatment programs will participate in 6 months of core sessions (all participants attend the same sessions), followed by 12 months of continuing sessions (where content is tailored to participants' needs). Staff will complete surveys about their knowledge and experience, and jails will provide data about their services. Researchers will measure changes in MOUD services offered by the jails over time, as well as the impact these changes have on staff's work environment. If Project ECHO helps expand MOUD services, it will offer a blueprint for expanding these life-saving services in other jails nationwide.

03

Conditions studied

  • Opioid Abuse (Disorder)

Keywords

  • Medications for Opioid Use Disorder
  • Rural Jails
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Administrative, security, or healthcare staff in participating jails
  • Employed at the facility a minimum of 3 months

Exclusion criteria

Exclusion Criteria:

  • Ongoing or recent participation in similar organizational improvement project
  • Inability to read or understand English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    ECHO

    Subjects participate in a series of facilitated ECHO learning sessions

    Behavioral: Project ECHO

Interventions

  • BehavioralProject ECHO

    Virtual learning sessions, case-based discussions, and peer-to-peer learning

06

What researchers measure

Primary outcomes

  1. Increase in MOUD prescriptions (administrative data)

    Administrative data tracking the number of MOUD prescriptions will be used to assess whether the jail has increased its use of MOUD to treat opioid use disorder relative to baseline.

    Time frame: From baseline through the end of sustainment phase (18 months)

Secondary outcomes

  1. Organizational climate - Burnout (BAT-4)

    Staff surveys measure Burnout via the 4-item Burnout Assessment Tool (BAT-4). Items are scored from 1 (never) to 5 (always), and the mean is calculated (higher scores = greater burnout). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.

    Time frame: From baseline to end of sustainment period (18 months)

  2. Organizational climate - Stress (TCU SOF subscale)

    Staff surveys measure Stress via a validated 4-item subscale of the TCU Survey of Organizational Functioning. Items are scored from 1 (disagree) to 5 (agree), and the mean is calculated (higher scores = greater perceived stress). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.

    Time frame: From baseline through end of sustainment period (18 months)

  3. Organizational climate - Job Satisfaction (TCU SOF subscale)

    Staff surveys measure job satisfaction using a 6-item validated subscale from the TCU Survey of Organizational Functioning. Items are scored from 1 (strongly disagree) to 5 (strongly agree), and the mean is calculated (higher scores = greater job satisfaction). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.

    Time frame: From baseline through end of sustainment period (18 months)

  4. Impact on Staff Knowledge: Opinions About MAT Questionnaire

    Staff surveys include this 12-item scale, measuring familiarity, receipt of training, and perceived effectiveness of 4 formulations of medications for opioid use disorder. Each item is rated on a 1-5 scale, with higher scores reflecting stronger endorsement. Overall improvements in any of the 3 domains relative to baseline will indicate the intervention had a positive impact on staff knowledge about MOUD.

    Time frame: From baseline through end of sustainment period (18 months)

  5. Disciplinary infractions (administrative data)

    Administrative data on the number and type of disciplinary infractions in past 6 months will assess the impact of MOUD service expansion on jail operations. Infractions are recorded as violent infractions; non-violent infractions; and instances of MOUD diversion.

    Time frame: From baseline through end of sustainment phase (18 months)

  6. Improvement on Opioid Services Cascade (BJS survey module)

    The BJS survey of opioid use disorder screening and treatment (supplement to the 2019 Annual Survey of Jails) measures service delivery (yes/no) using 12 items across 6 domains. An overall score is calculated by summing these responses, with higher scores relative to baseline indicating greater improvements in opioid treatment service delivery.

    Time frame: From baseline through end of sustainment period (18 months)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified data from responses to staff surveys

Supporting information: Study protocol, Informed consent form, Analytic code

Time frame: Analytic files upon publication or no later than end of study (May 2030), indefinitely via public archives

Access criteria: Data will be shared via NIH-approved public data repository (likely ICPSR). Registered users who consent to terms of data use agreement will be able to access deidentified data from staff surveys via download or within secure data enclave.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Feb 2030, 37 months later.

Of 465 non-industry interventional studies with no phase under Opioid-Related Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 47. This study's planned 37 months is above that.

Counting every sponsor, half of 496 studies reached it within 29 months; a quarter within 13 and three quarters within 46.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Jan 2027, on Oct 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 16, 2026
First posted
Jun 10, 2026
StartEst.
Jan 1, 2027was Sep 2026
Primary completionEst.
Feb 28, 2030
CompletionEst.
May 31, 2030
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 19, 2026
Sites
UMass Chan Medical School is now Recruiting
Oct 19, 2026
Start date
Sep 1, 2026→Jan 1, 2027
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Not yet recruiting→Recruiting
    UMass Chan Medical School is now Recruiting
    Start date Sep 1, 2026→Jan 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07637994
Responsible party
Rosemarie Martin (Professor, University of Massachusetts, Worcester) — Principal investigator
First posted
Jun 10, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Feb 28, 2030 (estimated)
Completion
May 31, 2030 (estimated)
Last update
Oct 19, 2026

Study contacts

JCOIN ECHO Coordinator
Contact
jcoinecho@umassmed.edu
508-856-3515

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion